Neo Kuma Ventures — Pre-Seed & Seed VC Firm ($150K–$1.0M Checks)
Neo Kuma Ventures is a Pre-Seed, Seed, Series A venture capital firm based in London, United Kingdom investing in Healthcare, AI / ML, SaaS. The firm typically writes $150K–$1.0M checks and has 12 portfolio companies in our records.
- Check size
- $150K–$1.0M
- Portfolio
- 12 companies on record
- Partners
- 2 listed
- Stage
- Pre-Seed, Seed, Series A
- Sectors
- Healthcare, AI / ML, SaaS
- HQ
- London, United Kingdom
- AUM
- Not in our records
Last verified: 2026-11-03
Pre-Seed, Seed, Series A
$150K – $1.0M
12+ companies
2 partners
Investment Thesis
Europe-focused specialist fund investing exclusively in psychedelic healthcare, with explicit interest in mental health, addiction, pain, clinical research, and digital therapeutics. The fund targets early-stage companies from pre-seed through Series A.
How Neo Kuma Ventures invests
Neo Kuma Ventures is a vc firm based in London, United Kingdom. The firm invests at the Pre-Seed, Seed, Series A stages, with a focus on Healthcare, AI / ML, SaaS.
Neo Kuma Ventures typically writes checks of $150K–$1.0M per investment.
Neo Kuma Ventures has backed 12 companies in our records, including Atai Lifescience, Beckley Psytech, Bright Minds Biosciences.
Partners & Team
Industry Focus
Invests In
Portfolio Companies (12)
Other
Atai Lifescience
Psychedelic mental-health platform developing and backing treatments for psychiatric disorders.
Beckley Psytech
Psychedelic medicine company focused on neuropsychiatric therapies.
Bright Minds Biosciences
Biopharma company developing next-generation serotonergic compounds.
Kanna Health
Health-tech company focused on psychedelic-assisted care.
Small Pharma
Biopharma company developing psychedelic-based treatments, including DMT programs.
Journey Clinical
Platform for ketamine-assisted psychotherapy and clinical support.
Wavepaths
Digital therapeutic company creating music- and experience-based tools for therapy.
Awakn Lifesciences
Company developing psychedelic therapies and addiction treatments.
Sana Health
Digital therapeutics company for chronic pain and related conditions.
Monument Therapeutics
Biopharma company researching psychedelic and neuropsychiatric treatments.
- •Raising at Pre-Seed, Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, AI / ML, SaaS — the sectors they actively back.
- •Size your ask to their typical $150K – $1.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Sean McLintock, Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Neo Kuma Ventures is a match for your startup
Upload your pitch deck to see how well you match with Neo Kuma Ventures and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal